Platelet aggregation and ApoE genotypes in the Framingham Heart Study
Jaime Ramos Cejudo, Luisa F Figueredo, Matthew R Scott, Sophia Lu, Alexa S Beiser, Saptaparni Ghosh, Ricardo S. Osorio, Thomas Wisniewski, Jeffrey S Berger, Sudha Seshadri, Andrew D Johnson · 2025
Read Platelet aggregation and ApoE genotypes in the Framingham Heart Study by Jaime Ramos Cejudo, Luisa F Figueredo, Matthew R Scott, Sophia Lu, Alexa S Beiser, Saptaparni Ghosh, Ricardo S. Osorio, Thomas Wisniewski, Jeffrey S Berger, Sudha Seshadri, Andrew D Johnson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709547.txt.
Description
Jaime Ramos Cejudo and co-authors examine, in a 2025 study, whether a gene tied to Alzheimer's disease also shapes how blood platelets clump. Carriers of the ApoE4 gene variant face higher risk of vessel damage and brain decline. Platelet clumping is a marker of vessel trouble, yet its link to the gene was untested. The team drew on the long-running Framingham Heart Study.
More than three thousand middle-aged adults with normal thinking gave blood for clumping tests and gene typing. The main test measured how platelets answered a standard trigger chemical. Models adjusted for age, sex, heart risk factors, and drugs that change platelet action. An older cohort from the same study served as a check. The work probes a possible route from a risk gene to vessel harm.
Catalog record
| CREATOR | Jaime Ramos Cejudo, Luisa F Figueredo, Matthew R Scott, Sophia Lu, Alexa S Beiser, Saptaparni Ghosh, Ricardo S. Osorio, Thomas Wisniewski, Jeffrey S Berger, Sudha Seshadri, Andrew D Johnson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |